Brought to you by:
VenoValve granted FDA Breakthrough Device designation
Hancock Jaffe Laboratories today (Wednesday, Aug. 4) announced that the Food and Drug Administration (FDA) has granted Breakthrough Device Designation status to the company’s VenoValve device, a potential treatment option for chronic venous insufficiency (CVI). “We are very pleased to…
SVS publishes DEI supplement to highlight challenges and opportunities within the specialty
With a firm eye on healing disparities in healthcare and within the vascular surgery specialty itself, the Society for Vascular Surgery (SVS) has published a 2021 diversity supplement as an addition to the August issue of the Journal of Vascular…
Surmodics announces successful first patient use of Pounce thrombectomy system
Surmodics has announced that J. Michael Bacharach, MD, a vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls, South Dakota, successfully treated the first patient with the company’s Pounce thrombectomy system. The procedure involved…
The choice between autonomy, true partnership—or the slow drift to ‘thralldom‘
Anthony Valdés, MBA, the president of Tampa, Florida-based Collaborative Health Systems, declares that what physicians want is to “deliver great clinical outcomes, get paid fairly for that care, and stay independent.” It is becoming clearer with every passing year that,…
LimFlow system a ‘cost-effective and high-value alternative’ to traditional therapies
Percutaneous deep vein arterialization (pDVA) with the LimFlow system offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent study published in the Journal of Critical Limb Ischemia. Peter Schneider, MD, professor of surgery at…
‘VSITE predicts Qualifying Exam success’
The Vascular Surgery In-Training Examination (VSITE) is “highly predictive” of a Vascular Qualifying Examination pass for examinees following both the integrated vascular surgery (0+5) and vascular fellowship (5+2) training paradigms, Vincent L. Rowe, MD, professor of surgery at the University…
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events inside and outside of medicine. As U.S. society has reckoned with the socioeconomic and cultural consequences…
Just 16% of US centers in VQI offer SVS guideline-compliant open repair for AAA, new study finds
There is a stark downward trend in the number of U.S. centers in the Vascular Quality Initiative (VQI) that meet the Society for Vascular Surgery (SVS) clinical practice guidelines for open repair of abdominal aortic aneurysm (AAA), new research to…
Artio Medical completes enrollment of first-in-human trial investigating Amplifi vein dilation system
Artio Medical announced today it has completed enrollment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated by Adrian Ebner, head of the cardiovascular department at Sanatorio Italiano Hospital in Asunción, Paraguay.…
The year in COVID: VAM to feature 10 talks probing pandemic-related vascular complications
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of COVID-19 in a special session. The coronavirus session will be from 5 to 6:30 p.m. Wednesday…